Economics of cancer related medical care: Worldwide estimates and available domestic evidence

Archive of Oncology

Volumn 19, Issue 3-4, 2011, Pages 59-63

  Radovanović, Ana ^a   Dagović, Aleksandar ^b   Jakovljević, Mihajlo ^a  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

^b CLINICAL CENTER KRAGUJEVAC   (Serbia)

Author keywords

Cost of illness; Health care costs; Health expenditures; Neoplasms; Radiation oncology; Serbia

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER RESEARCH; COST BENEFIT ANALYSIS; COST OF ILLNESS; HEALTH CARE COST; MALIGNANT NEOPLASTIC DISEASE; MEDICAL CARE; MEDICAL SERVICE; RESOURCE ALLOCATION; RETROSPECTIVE STUDY; TREND STUDY;

EID: 84860910698     PISSN: 03547310     EISSN: 14509520     Source Type: Journal    
DOI: 10.2298/AOO1104059R     Document Type: Article

References (25)

1. Landis S, Murray T, Bolden S, Wingo P. Cancer statistics, 1998. Ca Cancer J Clin. 1998;48:6-29.
2. World Health Organization. The Global Burden of Disease, 2004 update. Geneva: World Health Organization; 2008.
3. Yabroff R, Lawrence W, Clauser S, Davis W, Brown M. Burden of Illness in Cancer Survivors: Findings from a Population-Based National Sample. J Natl Cancer Inst. 2004;96:1322-30.
4. Uyl-de Groot C. Economic evaluation of cancer therapies: More and better studies will lead to better choices in cancer care. Eur J Cancer. 2006;42:2862-66.
5. World Health Organization. WHO media centre - global cancer rate could increase by 50 % to 15 million by 2020. Geneva; 2008.
6. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18:581-92.
7. Official Gazette of SRS no. 32/69. Beograd: Glasnik; 1969.
8. Health Statistical Yearbook of Republic of Serbia 2009. Belgrade: Institute of Public Health of Serbia; 2010.
9. Cancer incidence and mortality in central Serbia, Institute of public health of Serbia, Report No. X, Beograd; 2010.
10. Marsland T, Robbins G, Marks A, Cassel R, Philips DG, King K. Reducing cancer costs and improving quality trough collaboration with payers: A proposal from the Florida society of clinical oncology. J Oncol Pract. 2010;6:265-9.
11. Tangka F, Trogdon J, Richardson L, Hower D, Sabatino SA, Finkelstein EA. Cancer Treatment Cost in the United States. Has the Burden Shifted Over Time? Cancer. 2010;116:3477-8.
12. Bosanquet N, Sikora K. The economics of cancer care in the UK. Lancet Oncol. 2004;5:568-74.
13. Yabroff R, Lamont E, Mariotto A. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst. 2008;100:630-41.
14. Mullins D. An overview of cancer economic. Am J Manag Care. 1999;5:S371-76.
15. Kutikova L, Bowman L, Chang S, Long SR, Obasaju C, Crown WH. The economic burden of lung cancer and the associated costs of treatment failure in the United States. Lung Cancer. 2005;50:143-154.
16. Foster T, Miller J, Boye M, Blieden M, Gidwani R, Russell M. The economic burden of metastatic breast cancer: A systematic review of literature from developed countries. Cancer Treat Rev. 2011;37:405-15.
17. Kruse GB, Amonkar MM, Smith G, Skonieczny DC, Stavrakas S. Analysis of costs associated with administration of intravenous single-drug therapies in metastatic breast cancer in a US population. J Manag Care Pharm. 2008;14:844-57.
18. Lidgren M, Wilking N, Jonsson B, Rehnberg C. Resource use and costs associated with different states of breast cancer. Int J Technol Assess Health Care. 2007;23:223-31.
19. Lidgren M. Health economics of breast cancer (dissertation). Stockholm, Sweden: Karolonska Institute; 2007.
20. Blomqvist P, Lycke J, Strang P, Törnqvist H, Ekbom A. Brain tumors in Sweden 1996: care and costs. J Neurol Neurosurg Psychiatry. 2000;69:792-8.
21. Zavoral M, Suchanek S, Zavada F. Colorectal cancer screening in Europe. World J Gastroenterol. 2009;15:5907-15.
22. National Institutes of Health. Economic Costs of Cancer Health Disparities. Summary of Meeting Proceedings. U.S. Department of Health and Human Services; 2004.
23. Redaelli A, Botteman M, Stephens J, Brandt S, Pashos C. Economic burden of acute myeloid leukemia: a literature review. Cancer Treat Rev. 2004;30:237-47.
24. Fortner B, Demarco G, Irving G, Ashley J, Keppler G, Chavez J, Munk J. Description and Predictors of Direct and Indirect Costs of Pain Reported by Cancer Patients. J Pain Symptom Manage. 2003;25:9-18.
25. Lansdorp-Vogelaar I, Van Ballgooijen M, Zauber A, Habbema D, Kuipers E. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst. 2009; 101:1412-22.